These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 14973499

  • 1. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
    Kloosterboer FM, van Luxemburg-Heijs SA, van Soest RA, Barbui AM, van Egmond HM, Strijbosch MP, Kester MG, Marijt WA, Goulmy E, Willemze R, Falkenburg JH.
    Leukemia; 2004 Apr; 18(4):798-808. PubMed ID: 14973499
    [Abstract] [Full Text] [Related]

  • 2. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ, Ritz J.
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [Abstract] [Full Text] [Related]

  • 3. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM, van Luxemburg-Heijs SA, Rijnbeek M, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [Abstract] [Full Text] [Related]

  • 4. Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFNgamma-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusion.
    Kloosterboer FM, van Luxemburg-Heijs SA, van Soest RA, van Egmond HM, Barbui AM, Strijbosch MP, Willemze R, Falkenburg JH.
    Leukemia; 2005 Jan; 19(1):83-90. PubMed ID: 15526024
    [Abstract] [Full Text] [Related]

  • 5. Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells.
    von dem Borne PA, van Luxemburg-Heijs SA, Heemskerk MH, Jedema I, Mulder A, Willemze R, Falkenburg JH.
    Leukemia; 2006 Jun; 20(6):1040-6. PubMed ID: 16525495
    [Abstract] [Full Text] [Related]

  • 6. A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.
    de Rijke B, van Horssen-Zoetbrood A, Beekman JM, Otterud B, Maas F, Woestenenk R, Kester M, Leppert M, Schattenberg AV, de Witte T, van de Wiel-van Kemenade E, Dolstra H.
    J Clin Invest; 2005 Dec; 115(12):3506-16. PubMed ID: 16322791
    [Abstract] [Full Text] [Related]

  • 7. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA, Kernan NA, Diaz-Barrientos T, Veenhof WF, O'Reilly RJ, Willemze R, Falkenburg JH.
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [Abstract] [Full Text] [Related]

  • 8. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.
    Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA, van Luxemburg-Heys SA, Hoogeboom M, Mutis T, Drijfhout JW, van Rood JJ, Willemze R, Falkenburg JH.
    Proc Natl Acad Sci U S A; 2003 Mar 04; 100(5):2742-7. PubMed ID: 12601144
    [Abstract] [Full Text] [Related]

  • 9. A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes.
    Yazaki M, Takahashi T, Andho M, Akatsuka Y, Ito T, Miyake Y, Ito Y, Nakamura S, Wada Y.
    Bone Marrow Transplant; 1999 Jul 04; 24(2):129-37. PubMed ID: 10455340
    [Abstract] [Full Text] [Related]

  • 10. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM, van der Hoeven J, Goulmy E, Hooftman-den Otter AL, van Luxemburg-Heijs SA, Willemze R, Falkenburg JH.
    J Clin Invest; 1995 Aug 04; 96(2):877-83. PubMed ID: 7635982
    [Abstract] [Full Text] [Related]

  • 11. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
    Mutis T, Blokland E, Kester M, Schrama E, Goulmy E.
    Blood; 2002 Jul 15; 100(2):547-52. PubMed ID: 12091347
    [Abstract] [Full Text] [Related]

  • 12. Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion.
    Orsini E, Bellucci R, Alyea EP, Schlossman R, Canning C, McLaughlin S, Ghia P, Anderson KC, Ritz J.
    Cancer Res; 2003 May 15; 63(10):2561-8. PubMed ID: 12750280
    [Abstract] [Full Text] [Related]

  • 13. Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response.
    Takami A, Sugimori C, Feng X, Yachie A, Kondo Y, Nishimura R, Kuzushima K, Kotani T, Asakura H, Shiobara S, Nakao S.
    Bone Marrow Transplant; 2004 Oct 15; 34(8):703-9. PubMed ID: 15322566
    [Abstract] [Full Text] [Related]

  • 14. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
    Orsini E, Alyea EP, Schlossman R, Canning C, Soiffer RJ, Chillemi A, Neuberg D, Anderson KC, Ritz J.
    Bone Marrow Transplant; 2000 Mar 15; 25(6):623-32. PubMed ID: 10734296
    [Abstract] [Full Text] [Related]

  • 15. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
    Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E.
    Blood; 1999 Apr 01; 93(7):2336-41. PubMed ID: 10090944
    [Abstract] [Full Text] [Related]

  • 16. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
    van Balen P, Jedema I, van Loenen MM, de Boer R, van Egmond HM, Hagedoorn RS, Hoogstaten C, Veld SAJ, Hageman L, van Liempt PAG, Zwaginga JJ, Meij P, Veelken H, Falkenburg JHF, Heemskerk MHM.
    Front Immunol; 2020 Apr 01; 11():1804. PubMed ID: 32973756
    [Abstract] [Full Text] [Related]

  • 17. Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer.
    Mommaas B, van Halteren AG, Pool J, van der Veken L, Wieles B, Heemskerk MH, Goulmy E.
    Haematologica; 2005 Oct 01; 90(10):1415-21. PubMed ID: 16219579
    [Abstract] [Full Text] [Related]

  • 18. Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.
    Claret EJ, Alyea EP, Orsini E, Pickett CC, Collins H, Wang Y, Neuberg D, Soiffer RJ, Ritz J.
    J Clin Invest; 1997 Aug 15; 100(4):855-66. PubMed ID: 9259585
    [Abstract] [Full Text] [Related]

  • 19. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
    Hudecek M, Bartsch K, Tschiedel S, Niederwieser D.
    Dtsch Med Wochenschr; 2008 Jul 15; 133(28-29):1511-6. PubMed ID: 18597211
    [Abstract] [Full Text] [Related]

  • 20. Efficient activation of LRH-1-specific CD8+ T-cell responses from transplanted leukemia patients by stimulation with P2X5 mRNA-electroporated dendritic cells.
    Overes IM, Fredrix H, Kester MG, Falkenburg JH, van der Voort R, de Witte TM, Dolstra H.
    J Immunother; 2009 Jul 15; 32(6):539-51. PubMed ID: 19483655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.